REGISTERED
on 29 Oct 2024
Last Applicant/ Owned by
228 Park Ave. South
New York
NY
10003
Serial Number
97603698 filed on 23rd Sep 2022
Registration Number
7547212 registered on 29th Oct 2024
Correspondent Address
Matthew D. Delaney
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
OVIVA THERAPEUTICS
Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of ovarian function; Research and development in the field of female physiology; Scientific research for medical purposes in the field of ovarian function; Scientific research for medical purposes in the fie Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of ovarian function; Research and development in the field of female physiology; Scientific research for medical purposes in the field of ovarian function; Scientific research for medical purposes in the field of female physiology
First Use Date in General
31st Jan 2022
First Use Date in Commerce
31st Jan 2022
Mark Details
Serial Number
No 97603698
Mark Type
No Service Mark
Attorney Docket Number
No 0742354
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Aug 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Aug 2024 | PUBLISHED FOR OPPOSITION |
| 24th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 05th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 03rd Jul 2024 | ASSIGNED TO LIE |
| 03rd Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 03rd Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 10th Jan 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |